Table 2.
Characteristics of the study sample by hsCRP and NT-proBNP tertiles.
| High-sensitivity C-reactive protein in tertiles | p | N-terminal pro-B-type natriuretic peptide in tertiles | p | |||||
|---|---|---|---|---|---|---|---|---|
| Lowest <0.59 ml/l |
Middle 0.59-1.40 ml/l |
Highest >1.40 ml/l |
Lowest <54.10 nl/l |
Middle 54.10-163.77 nl/l |
Highest >163.77 nl/l |
|||
| Gender | ||||||||
| Male | 26 (39.4) | 18 (27.3) | 22 (32.2) | 0.15 | 29 (44.6) | 19 (29.2) | 17 (26.2) | 0.04 |
| Female | 31 (29.2) | 44 (41.5) | 31 (29.2) | 28 (26.7) | 39 (36.4) | 40 (37.4) | ||
| Age | ||||||||
| Age in years | 52.3 (14.6) | 57.4 (14.4) | 59.5 (13.5) | 0.02 | 46.1 (13.1) | 57.8 (12.2) | 64.3 (11.5) | <0.01 |
| Marital status | ||||||||
| Living alone | 14 (27.5) | 22 (43.1) | 15 (29.4) | 0.41 | 13 (24.5) | 19 (35.8) | 21 (39.6) | 0.25 |
| With partner | 43 (35.5) | 40 (33.1) | 38 (31.4) | 44 (37.0) | 39 (32.8) | 36 (30.3) | ||
| Education | ||||||||
| <=12 years | 21 (31.8) | 24 (36.4) | 21 (31.8) | 0.95 | 19 (29.7) | 21 (32.8) | 24 (37.5) | 0.61 |
| >12 years | 36 (34.0) | 38 (35.8) | 32 (30.2) | 38 (35.2) | 37 (34.3) | 33 (30.6) | ||
| Cardiovascular disease | ||||||||
| No | 49 (38.0) | 46 (35.7) | 34 (26.4) | 0.03 | 50 (38.2) | 48 (36.6) | 33 (25.2) | <0.01 |
| Yes | 8 (18.6) | 16 (37.2) | 19 (44.2) | 7 (17.1) | 10 (24.4) | 24 (58.5) | ||
| Functional status | ||||||||
| KPI | 83.9 (13.2) | 85.2 (10.9) | 86.7 (9.2) | 0.43 | 86.9 (10.0) | 84.5 (10.6) | 84.6 (12.4) | 0.43 |
| Tumor side | ||||||||
| Right | 22 (28.9) | 31 (40.8) | 23 (30.3) | 0.07 | 28 (36.4) | 25 (32.5) | 24 (31.2) | 0.56 |
| Left | 32 (42.7) | 20 (26.7) | 23 (30.7) | 25 (34.2) | 25 (34.2) | 23 (31.5) | ||
| Bifrontal | 3 (14.3) | 11 (52.4) | 7 (33.3) | 4 (18.2) | 8 (36.4) | 10 (45.5) | ||
| Tumor location | ||||||||
| Involving frontal and/or temporal lobes | 47 (35.3) | 44 (33.1) | 42 (31.6) | 0.30 | 48 (36.4) | 43 (32.6) | 41 (31.1) | 0.25 |
| Other | 10 (25.6) | 18 (46.2) | 11 (28.2) | 9 (22.5) | 15 (37.5) | 16 (40.0) | ||
| Type of the tumor | ||||||||
| I-II grade glioma | 10 (40.0) | 6 (24.0) | 9 (36.0) | 0.55 | 17 (68.0) | 6 (24.0) | 2 (8.0) | <0.01 |
| III-IV grade glioma | 23 (35.9) | 23 (35.9) | 18 (28.1) | 21 (32.3) | 22 (33.8) | 22 (33.8) | ||
| Meningioma | 24 (28.9) | 33 (39.8) | 26 (31.3) | 19 (23.2) | 30 (36.6) | 33 (40.2) | ||